Table 1.
Patients profile.
| Patient number |
Age (years) |
Gender | Sampled hemisphere |
Number of included electrodes (depth/subdural) |
Antiepileptic drugs |
Age of epilepsy onset (years) |
SOZ | Pathology |
|---|---|---|---|---|---|---|---|---|
| 1 | 12 | Male | Both | 90 / 0 | LTG, LAC | 6 | Both F | Not applicable |
| 2 | 12 | Female | Both | 129 / 0 | LEV, LAC, CLB | 2 | Lt F | Dysplasia |
| 3 | 16 | Female | Both | 128 / 0 | LEV, LTG, OXC | 9 | Rt F | Gliosis |
| 4 | 2 | Male | Right | 8 / 125 | LEV, OXC, CLB | 0 | F, P | Dysplasia |
| 5 | 4 | Female | Right | 6 / 137 | LAC | 0 | F, P | Dysplasia |
| 6 | 8 | Male | Left | 13 / 99 | LEV, OXC | 6 | P | Dysplasia |
| 7 | 8 | Female | Right | 6 / 113 | LAC, OXC, CLB | 2.5 | P | Gliosis |
| 8 | 12 | Male | Left | 7 / 98 | VPA, LEV | 7 | P | Dysplasia |
| 9 | 13 | Male | Left | 11 / 96 | LEV, LAC | 10 | O | Dysplasia |
| 10 | 13 | Male | Right | 2 / 128 | LEV, OXC | 11 | F | Dysplasia |
| 11 | 16 | Female | Left | 15 / 110 | OXC | 7 | P, T | Dysplasia |
| 12 | 16 | Female | Right | 8 / 116 | ZNS, LTG | 6 | P | Gliosis |
| 13 | 17 | Female | Left | 8 / 114 | LTG | 15 | T | Gliosis |
| 14 | 19 | Male | Right | 8 / 116 | LEV, OXC | 0 | O | Dysplasia |
SOZ: Seizure onset zone. LTG: Lamotrigine. LAC: Lacosamide. LEV: Levetiracetam. CLB: Clobazam. OXC: Oxcarbazepine. VPA: Valproate. ZNS: Zonisamide. F: Frontal. P: Parietal. T: Temporal. O: Occipital.